Compounding Group Open To Oversight Talks With FDA
The International Academy of Compounding Pharmacists said Friday that it's willing to discuss the U.S. Food and Drug Administration's desire to define some compounders that resemble drug manufacturers as "nontraditional compounding...To view the full article, register now.
Already a subscriber? Click here to view full article